InChI=1S/C22H32O5/c1- 2- 3- 9- 16- 20(24) 21(25) 17- 12- 7- 5- 4- 6- 10- 14- 19(23) 15- 11- 8- 13- 18- 22(26) 27/h3- 12,14,17,19- 21,23- 25H,2,13,15- 16,18H2,1H3,(H,26,27) /b6- 4- ,7- 5+,9- 3- ,11- 8- ,14- 10+,17- 12+/t19- ,20+,21+/m0/s1 |
IKFAUGXNBOBQDM-VSXQVJIISA-N |
C(C(O)=O)C/C=C\C[C@H](\C=C\C=C/C=C/C=C/[C@H]([C@@H](C/C=C\CC)O)O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(4Z,7R,8E,10Z,12E,14E,16R,17R,19Z)- 7,16,17- trihydroxydocosa- 4,8,10,12,14,19- hexaenoic acid
|
(4Z,7R,8E,10Z,12E,14E,16R,17R,19Z)- 7,16,17- trihydroxydocosahexaenoic acid
|
ChEBI
|
17-epi-resolvin D2
|
ChEBI
|
17-epi-RvD2
|
ChEBI
|
7S,16R,17R-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid
|
LIPID MAPS
|
aspirin-triggered resolvin D2
|
ChEBI
|
aspirin-triggered RvD2
|
ChEBI
|
AT-RvD2
|
SUBMITTER
|
|